List of Tables
Table 1. Global Tuberculosis Vaccine Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Tuberculosis Vaccine Drug Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Tuberculosis Vaccine Drug Market Competitive Situation by Manufacturers in 2024
Table 4. Global Tuberculosis Vaccine Drug Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Tuberculosis Vaccine Drug Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Tuberculosis Vaccine Drug Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Tuberculosis Vaccine Drug Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Tuberculosis Vaccine Drug Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Tuberculosis Vaccine Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Tuberculosis Vaccine Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Tuberculosis Vaccine Drug, Product Type & Application
Table 12. Global Key Manufacturers of Tuberculosis Vaccine Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Tuberculosis Vaccine Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Vaccine Drug as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Tuberculosis Vaccine Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Tuberculosis Vaccine Drug Sales by Region (2020-2025) & (K Units)
Table 18. Global Tuberculosis Vaccine Drug Sales Market Share by Region (2020-2025)
Table 19. Global Tuberculosis Vaccine Drug Sales by Region (2026-2031) & (K Units)
Table 20. Global Tuberculosis Vaccine Drug Sales Market Share by Region (2026-2031)
Table 21. Global Tuberculosis Vaccine Drug Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Tuberculosis Vaccine Drug Revenue Market Share by Region (2020-2025)
Table 23. Global Tuberculosis Vaccine Drug Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Tuberculosis Vaccine Drug Revenue Market Share by Region (2026-2031)
Table 25. North America Tuberculosis Vaccine Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Tuberculosis Vaccine Drug Sales by Country (2020-2025) & (K Units)
Table 27. North America Tuberculosis Vaccine Drug Sales by Country (2026-2031) & (K Units)
Table 28. North America Tuberculosis Vaccine Drug Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Tuberculosis Vaccine Drug Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Tuberculosis Vaccine Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Tuberculosis Vaccine Drug Sales by Country (2020-2025) & (K Units)
Table 32. Europe Tuberculosis Vaccine Drug Sales by Country (2026-2031) & (K Units)
Table 33. Europe Tuberculosis Vaccine Drug Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Tuberculosis Vaccine Drug Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Tuberculosis Vaccine Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Tuberculosis Vaccine Drug Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Tuberculosis Vaccine Drug Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Tuberculosis Vaccine Drug Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Tuberculosis Vaccine Drug Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Tuberculosis Vaccine Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Tuberculosis Vaccine Drug Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Tuberculosis Vaccine Drug Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Tuberculosis Vaccine Drug Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Tuberculosis Vaccine Drug Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Tuberculosis Vaccine Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Tuberculosis Vaccine Drug Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Tuberculosis Vaccine Drug Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Tuberculosis Vaccine Drug Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Tuberculosis Vaccine Drug Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Tuberculosis Vaccine Drug Sales (K Units) by Type (2020-2025)
Table 51. Global Tuberculosis Vaccine Drug Sales (K Units) by Type (2026-2031)
Table 52. Global Tuberculosis Vaccine Drug Sales Market Share by Type (2020-2025)
Table 53. Global Tuberculosis Vaccine Drug Sales Market Share by Type (2026-2031)
Table 54. Global Tuberculosis Vaccine Drug Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Tuberculosis Vaccine Drug Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Tuberculosis Vaccine Drug Revenue Market Share by Type (2020-2025)
Table 57. Global Tuberculosis Vaccine Drug Revenue Market Share by Type (2026-2031)
Table 58. Global Tuberculosis Vaccine Drug Price (US$/Unit) by Type (2020-2025)
Table 59. Global Tuberculosis Vaccine Drug Price (US$/Unit) by Type (2026-2031)
Table 60. Global Tuberculosis Vaccine Drug Sales (K Units) by Application (2020-2025)
Table 61. Global Tuberculosis Vaccine Drug Sales (K Units) by Application (2026-2031)
Table 62. Global Tuberculosis Vaccine Drug Sales Market Share by Application (2020-2025)
Table 63. Global Tuberculosis Vaccine Drug Sales Market Share by Application (2026-2031)
Table 64. Global Tuberculosis Vaccine Drug Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Tuberculosis Vaccine Drug Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Tuberculosis Vaccine Drug Revenue Market Share by Application (2020-2025)
Table 67. Global Tuberculosis Vaccine Drug Revenue Market Share by Application (2026-2031)
Table 68. Global Tuberculosis Vaccine Drug Price (US$/Unit) by Application (2020-2025)
Table 69. Global Tuberculosis Vaccine Drug Price (US$/Unit) by Application (2026-2031)
Table 70. Merck Company Information
Table 71. Merck Description and Business Overview
Table 72. Merck Tuberculosis Vaccine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Merck Tuberculosis Vaccine Drug Product
Table 74. Merck Recent Developments/Updates
Table 75. Japan BCG Lab Company Information
Table 76. Japan BCG Lab Description and Business Overview
Table 77. Japan BCG Lab Tuberculosis Vaccine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Japan BCG Lab Tuberculosis Vaccine Drug Product
Table 79. Japan BCG Lab Recent Developments/Updates
Table 80. Serum Institute of India Company Information
Table 81. Serum Institute of India Description and Business Overview
Table 82. Serum Institute of India Tuberculosis Vaccine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Serum Institute of India Tuberculosis Vaccine Drug Product
Table 84. Serum Institute of India Recent Developments/Updates
Table 85. AJ Vaccines Company Information
Table 86. AJ Vaccines Description and Business Overview
Table 87. AJ Vaccines Tuberculosis Vaccine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. AJ Vaccines Tuberculosis Vaccine Drug Product
Table 89. AJ Vaccines Recent Developments/Updates
Table 90. BioFarma Company Information
Table 91. BioFarma Description and Business Overview
Table 92. BioFarma Tuberculosis Vaccine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. BioFarma Tuberculosis Vaccine Drug Product
Table 94. BioFarma Recent Developments/Updates
Table 95. GreenSignal Bio Pharma Company Information
Table 96. GreenSignal Bio Pharma Description and Business Overview
Table 97. GreenSignal Bio Pharma Tuberculosis Vaccine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. GreenSignal Bio Pharma Tuberculosis Vaccine Drug Product
Table 99. GreenSignal Bio Pharma Recent Developments/Updates
Table 100. China National Biotec Company Information
Table 101. China National Biotec Description and Business Overview
Table 102. China National Biotec Tuberculosis Vaccine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. China National Biotec Tuberculosis Vaccine Drug Product
Table 104. China National Biotec Recent Developments/Updates
Table 105. Biomed Lublin Company Information
Table 106. Biomed Lublin Description and Business Overview
Table 107. Biomed Lublin Tuberculosis Vaccine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Biomed Lublin Tuberculosis Vaccine Drug Product
Table 109. Biomed Lublin Recent Developments/Updates
Table 110. Taj Pharmaceuticals Company Information
Table 111. Taj Pharmaceuticals Description and Business Overview
Table 112. Taj Pharmaceuticals Tuberculosis Vaccine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Taj Pharmaceuticals Tuberculosis Vaccine Drug Product
Table 114. Taj Pharmaceuticals Recent Developments/Updates
Table 115. Ataulpho de Paiva Company Information
Table 116. Ataulpho de Paiva Description and Business Overview
Table 117. Ataulpho de Paiva Tuberculosis Vaccine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Ataulpho de Paiva Tuberculosis Vaccine Drug Product
Table 119. Ataulpho de Paiva Recent Developments/Updates
Table 120. IVAC Company Information
Table 121. IVAC Description and Business Overview
Table 122. IVAC Tuberculosis Vaccine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. IVAC Tuberculosis Vaccine Drug Product
Table 124. IVAC Recent Developments/Updates
Table 125. Queen Saovabha Mem. Inst Company Information
Table 126. Queen Saovabha Mem. Inst Description and Business Overview
Table 127. Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Product
Table 129. Queen Saovabha Mem. Inst Recent Developments/Updates
Table 130. Microgen Company Information
Table 131. Microgen Description and Business Overview
Table 132. Microgen Tuberculosis Vaccine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Microgen Tuberculosis Vaccine Drug Product
Table 134. Microgen Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Tuberculosis Vaccine Drug Distributors List
Table 138. Tuberculosis Vaccine Drug Customers List
Table 139. Tuberculosis Vaccine Drug Market Trends
Table 140. Tuberculosis Vaccine Drug Market Drivers
Table 141. Tuberculosis Vaccine Drug Market Challenges
Table 142. Tuberculosis Vaccine Drug Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Tuberculosis Vaccine Drug
Figure 2. Global Tuberculosis Vaccine Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Tuberculosis Vaccine Drug Market Share by Type: 2024 & 2031
Figure 4. Immune Vaccine Product Picture
Figure 5. Therapy Vaccine Product Picture
Figure 6. Global Tuberculosis Vaccine Drug Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Tuberculosis Vaccine Drug Market Share by Application: 2024 & 2031
Figure 8. Self-Procurement
Figure 9. UNICEF
Figure 10. Other
Figure 11. Global Tuberculosis Vaccine Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Tuberculosis Vaccine Drug Market Size (2020-2031) & (US$ Million)
Figure 13. Global Tuberculosis Vaccine Drug Sales (2020-2031) & (K Units)
Figure 14. Global Tuberculosis Vaccine Drug Average Price (US$/Unit) & (2020-2031)
Figure 15. Tuberculosis Vaccine Drug Report Years Considered
Figure 16. Tuberculosis Vaccine Drug Sales Share by Manufacturers in 2024
Figure 17. Global Tuberculosis Vaccine Drug Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Tuberculosis Vaccine Drug Players: Market Share by Revenue in Tuberculosis Vaccine Drug in 2024
Figure 19. Tuberculosis Vaccine Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Tuberculosis Vaccine Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Tuberculosis Vaccine Drug Sales Market Share by Country (2020-2031)
Figure 22. North America Tuberculosis Vaccine Drug Revenue Market Share by Country (2020-2031)
Figure 23. United States Tuberculosis Vaccine Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Tuberculosis Vaccine Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Tuberculosis Vaccine Drug Sales Market Share by Country (2020-2031)
Figure 26. Europe Tuberculosis Vaccine Drug Revenue Market Share by Country (2020-2031)
Figure 27. Germany Tuberculosis Vaccine Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Tuberculosis Vaccine Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Tuberculosis Vaccine Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Tuberculosis Vaccine Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Tuberculosis Vaccine Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Tuberculosis Vaccine Drug Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Tuberculosis Vaccine Drug Revenue Market Share by Region (2020-2031)
Figure 34. China Tuberculosis Vaccine Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Tuberculosis Vaccine Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Tuberculosis Vaccine Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Tuberculosis Vaccine Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Tuberculosis Vaccine Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Tuberculosis Vaccine Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Tuberculosis Vaccine Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Tuberculosis Vaccine Drug Sales Market Share by Country (2020-2031)
Figure 42. Latin America Tuberculosis Vaccine Drug Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Tuberculosis Vaccine Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Tuberculosis Vaccine Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Tuberculosis Vaccine Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa Tuberculosis Vaccine Drug Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Tuberculosis Vaccine Drug Revenue Market Share by Country (2020-2031)
Figure 48. Turkey Tuberculosis Vaccine Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Tuberculosis Vaccine Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE Tuberculosis Vaccine Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of Tuberculosis Vaccine Drug by Type (2020-2031)
Figure 52. Global Revenue Market Share of Tuberculosis Vaccine Drug by Type (2020-2031)
Figure 53. Global Tuberculosis Vaccine Drug Price (US$/Unit) by Type (2020-2031)
Figure 54. Global Sales Market Share of Tuberculosis Vaccine Drug by Application (2020-2031)
Figure 55. Global Revenue Market Share of Tuberculosis Vaccine Drug by Application (2020-2031)
Figure 56. Global Tuberculosis Vaccine Drug Price (US$/Unit) by Application (2020-2031)
Figure 57. Tuberculosis Vaccine Drug Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
